 | Up a level |
Violato, M, Dakin, H, Chakravarthy, U, Reeves, BC, Peto, T, Hogg, RE, Harding, SP 
ORCID: 0000-0003-4676-1158, Scott, LJ, Taylor, J, Cappel-Porter, H et al (show 4 more authors)
(2016)
Cost-effectiveness of community versus hospital eye service follow-up for patients with quiescent treated age-related macular degeneration alongside the ECHoES randomised trial.
BMJ OPEN, 6 (10).
e011121-.
Reeves, BC, Scott, LJ, Taylor, J, Harding, SP ORCID: 0000-0003-4676-1158, Peto, T, Muldrew, A, Hogg, RE, Wordsworth, S, Mills, N, O'Reilly, D et al (show 2 more authors)
(2016)
Effectiveness of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual non-inferiority trial.
BMJ Open, 6 (7).
e010685-.
Reeves, BC, Scott, LJ, Taylor, J, Hogg, R, Rogers, CA, Wordsworth, S, Townsend, D, Muldrew, A, Peto, T, Violato, M et al (show 6 more authors)
(2016)
The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trial.
Health technology assessment (Winchester, England), 20 (80).
pp. 1-120.
Lucas, CM ORCID: 0000-0001-6674-7535, Milani, M, Butterworth, M, Carmell, N, Scott, LJ, Clark, RE ORCID: 0000-0002-1261-3299, Cohen, GM and Varadarajan, S ORCID: 0000-0002-8827-6567
(2016)
High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-X-L in chronic myeloid leukemia.
LEUKEMIA, 30 (6).
pp. 1273-1281.